Interact to see
Advertisement
Advertisement
ESERX vs RGACX
ESERX vs RGACX Comparison
Open Charts ESERX vs RGACX
ESERX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ESERX vs. RGACX commentary
Sep 10, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESERX is a Hold and RGACX is a StrongBuy.
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 353B vs. ESERX (232M). ESERX (0.00) and RGACX (0.00) have matching dividends . ESERX was incepted earlier than RGACX: ESERX (10 years) vs RGACX (24 years). RGACX (0.93) is less costly to investors than ESERX (0.76). RGACX is a more actively managed with annual turnover of: 32.00 vs. ESERX (12.00). RGACX has a lower initial minimum investment than ESERX: RGACX (250) vs ESERX (5000000). RGACX annual gain was more profitable for investors over the last year : 0.87 vs. ESERX (-22.92). RGACX return over 5 years is better than : 11.29 vs. ESERX (-21.12).
| ESERX | RGACX | ESERX / RGACX | |
| Total Expense Ratio | 0.75 | 0.93 | 81% |
| Annual Report Gross Expense Ratio | 0.76 | 0.93 | 82% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | -6.648 | 9.283 | -72% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 250 | 2,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 232M | 353B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -22.92 | 0.87 | -2,634% |
| Returns for 3 years | -12.44 | 41.63 | -30% |
| Returns for 5 years | -21.12 | 11.29 | -187% |
| Returns for 10 years | N/A | 101.73 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYCFX | 53.90 | N/A | N/A |
| Rydex Biotechnology C | |||
| FDTCX | 37.28 | N/A | N/A |
| Fidelity Advisor Diversified Stock C | |||
| VLACX | 142.54 | N/A | N/A |
| Vanguard MStar Large Cap Index Investor | |||
| CRIHX | 13.29 | N/A | N/A |
| CRM Long/Short Opportunities Instl | |||
| AVEEX | 18.29 | -0.06 | -0.33% |
| Avantis® Emerging Markets Equity Instl | |||